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Background: The beneficial effects of the Mediterranean diet have been amply proven in adults with
cardiovascular risk factors. The effects of this diet have not been extensively assessed in pediatric populations with
obesity, insulin resistance (IR) and metabolic syndrome (MetS). The aim of this study was to assess the efficacy of
the Mediterranean style diet (MSD) to decrease cardiovascular risk factors in children and adolescents with obesity.
Methods: Participants were randomly assigned to a MSD rich in polyunsaturated fatty acids, fiber, flavonoids and
antioxidants (60% of energy from carbohydrate, 25% from fat, and 15% from protein, (n = 24); or a standard diet
(55% of carbohydrate, 30% from fat and 15% from protein, (n = 25), the caloric ingest was individualized. At baseline
and 16-week of intervention, the glucose, triglycerides (TG), total cholesterol (TC), HDL-C, LDL-C were measured as
well as the body composition and anthropometric data. The diet compliance was determined by the 24-hour
recalls.
Paired Student’s t and Macnemar’s test were used to compare effects in biochemical, body composition,
anthropometric, and dietary variables.
Results: The MSD group had a significantly decrease in BMI, lean mass, fat mass, glucose, TC, TG, HDL-C and LDL-C.
(p < 0.05); the diet compliance increased consumption of omega 9 fatty acids, zinc, vitamin E, selenium, and
decreased consumption of saturated fatty acids (p < 0.05). The standard diet group decrease in glucose levels and
frequency of glucose >100 mg/dL (p < 0.05).
Conclusion: The MSD improves the BMI, glucose and lipid profile in children and adolescents with obesity and any
MetS component.
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Over the last three decades, there has been a docu-
mented increase in the prevalence of pediatric obesity
worldwide [1]. In Mexico, the 2006 National Survey of
Health and Nutrition reported a 26.8% combined preva-
lence of overweight and obese children aged 5 to 11. In
2012, the national combined prevalence of overweight and
obese children aged 5 to 11 was 34.4% (19.8 and 14.6%,* Correspondence: lubia2002@yahoo.com.mx
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article, unless otherwise stated.respectively), whereas 35% of adolescents were overweight
or obese [2].
As previously reported, the predicting factors that are
most tightly linked to metabolic syndrome (MetS) are
obesity and insulin resistance (IR). A study reported that
90% of obese adolescents present with at least one MetS
component, whereas 30% meet all MetS criteria [3], in-
cluding abdominal obesity, dyslipidemia (increase in
triglycerides [TG] and low high-density lipoprotein
cholesterol [HDL-C] levels), high blood pressure and
glucose intolerance [4,5]. The importance and interest in
MetS lies in its association with type 2 diabetes mellitusd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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even in subjects without T2DM [6].
The beneficial effects of poly- and monounsaturated
fats on the recommended indexes for omega-3 (ω3) have
been determined to result in decreased obesity and IR
[7]. Additionally, the association between the glycemic
index (GI) and glycemic load (GL) with Homeostatic
Model Assessment of IR index (HOMA-IR) has been
established, as well as the prevalence of MetS when
foods with a high GI are consumed. The beneficial effect
of high-fiber cereals and whole grains has also been
demonstrated [8].
A diet rich in soluble fiber (20 g/1000 kcal) and low in
polyunsaturated fats (20% of total calories) and a de-
creased consumption of food items with a high GI, can
decrease the prevalence of MetS by improving blood
pressure (BP) and IR [9,10]. Weight loss improves insu-
lin sensitivity and decreases visceral fat content. The level
of oxidative stress is increased in patients with MetS, caus-
ing an endogenous and exogenous depletion of antioxi-
dant reserves. Patients with MetS do not consume enough
fruit and vegetables, so it is necessary to increase their in-
take to meet vitamin C and carotenoid quotas [11].
Over the last few decades, the Mediterranean diet has
been shown to decrease cardiovascular events and increase
life expectancy in adult populations [12-14].
Similarly, it has been shown to efficiently decrease MetS
by 20-43%, regardless of age, sex, physical activity, lipid
levels, and BP [15]. This type of diet characteristically uses
olive oil, both as a dressing and to cook food, and contains
fish, wheat, olives, and grapes [16,17].
The beneficial effects of the Mediterranean diet have
been proven. Similarly, in combination with dried fruits,
its main component, olive oil, has been shown to decrease
total cholesterol (TC) and TG levels [18,19].
The effect of a Mediterranean-style diet (MSD) has not
been extensively assessed in pediatric populations pre-
senting with cardiovascular risk factors. Thus, the ob-
jective of the present study was to assess the efficacy of
nutritional therapy using an MSD to decrease MetS in-
dicators in obese children and adolescents.
Methods
An open-label study was conducted in 49 children and ado-
lescents attending the family medicine unit at the Mexican
Social Security Institute. The subjects were selected from a
multicentric study in Mexico called “Prevention and early
treatment of T2D in a pediatric population”. Subjects
meeting the following criteria were selected: Body Mass
Index (BMI) ≥95th percentile and any MetS component,
according to modified International Diabetes Federation
(IDF) criteria for children and adolescents; waist circumfer-
ence (WC) ≥90th percentile; fasting glucose ≥100 mg/dL;
TG ≥150 mg/dL; HDL-C ≤ 40 mg/dL; systolic bloodpressure (SBP) ≥130 mmHg and/ or diastolic blood
pressure (DBP) ≥85 mmHg [20]. On beginning the
study, none of the participating candidates presented
any chronic illness, nor were they receiving pharmaco-
logical treatment for obesity and/or its comorbidities
that would limit their participation in the dietetic inter-
vention. This research was conducted in accordance
with the Declaration of Helsinki, 59th WMA General
Assembly, Seoul, Republic of Korea, October 2008 for
research involving human subjects. Ethical approval was
obtained from the Research Ethics Committee at the
Carlos Macgregor Sanchez Navarro Hospital, Mexico
City. Written consent was provided by all participants
and their parents before enrollment.
Clinical history was obtained and a complete examin-
ation was carried out for all participants. The presence of
acanthosis nigricans in the neck and armpits was assessed.
SBP and DBP were measured three times with a 5 min
interval between measurements, with the patient having
remained seated for more than 5 min. The arterial pres-
sure value was determined from the average of the last
two measurements. Anthropometric measurements were
recorded by nutritionists and standardized using the
Habicht method according to the specifications recom-
mended by Lohman et al. [21,22].
Weight and height were measured using a TANITA™
scale (model TBF-215), which provides information on fat
percentage, fat mass, and lean body mass in kilograms
using bioelectrical impedance of the lower segments. WC
was measured after determining the midpoint between
the last rib and the upper edge of the iliac crest on the
right-hand side. Hip circumference was determined at the
widest point of the trochanters. Both measurements were
taken three times, and the average values of the second
and third measurements were used for the analysis.
TC and TG concentrations were measured by enzymatic
methods. HDL-C was quantified after precipitation of li-
poproteins containing apoB with phosphotungstate/
Mg2+; low density lipoprotein cholesterol. Low density
lipoprotein cholesterol (LDL-C) levels were estimated
using the Friedewald formula as modified by DeLong et al.
[23]. HOMA-IR was calculated as the product of the
fasting plasma insulin level in microunits and the fasting
plasma glucose level in millimoles per liter, divided by
22.5 [24].
Using a radioimmunoanalysis method, glucose and in-
sulin levels were determined while fasting, and 2 hours
after the administration of an oral load of 1. 75 g of hy-
dric glucose per kg of body weight, (maximal dose of
75 g). All biochemical indicators, except for post-load
glucose and insulin levels, were measured again after 16-
week follow-up.
Prior to the start of both diets, the patients and their
families were trained how to build a healthy menu based
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instruction and the main food groups included fruits,
vegetables, meats, dairy, cereals, legumes, and fats.
Following the first month of instruction, 24 children
and adolescents received the Mediterranean-style diet
(MSD) and 25 received the standard diet. The Schofield
equation was used for dietary calculations in children
aged 3–10 and adolescents aged 10–18. The food re-
ceived by the standard diet group was distributed with
55-60% of carbohydrates (45-50% complex and no more
than 10% refined and processed sugars), 25-30% lipids,
and 15% proteins. In accordance with the calories corre-
sponding to them, each patient was encouraged to con-
sume fresh fruit and vegetables, while any dairy products
and products of animal origin should be low in fat. It
was recommended that they limit their consumption of
fried food, while the consumption of steamed foods was en-
couraged. It was suggested that eating times be respected
and that food should preferably be consumed at home. It
was also suggested that the consumption of fast food be
limited to once a month or less. The consumption of sug-
ary drinks and packaged juices was limited, while the con-
sumption of natural water was encouraged along with
drinks prepared using fruit but no added sugar. As well as
receiving the aforementioned recommendations, the MSD
group also received the following specific indications re-
garding distribution: 60% carbohydrates (50% complex
and no more than 10% refined and processed sugars), 25%
lipids, and 15% proteins. It was also recommended that
they consume foods rich in a) essential fatty acids, such as
safflower, corn, olive, and soy oils; b) omega 3 fatty acids
(alpha-linolenic acid, eicosapentaenoic acid (EPA), and
docosahexaenoic acid (DHA), found in foods such as sal-
mon, mackerel, tuna, grouper, anchovies, flaxseed, canola,
walnuts, and wheat germ; c) omega 9 fatty acids (oleic and
erucic acids), found in olive and canola oils, as well as Ery-
simum and mustard seeds; d) antioxidants, such as beta
carotenes, lycopenes, vitamin A, vitamin C (found in pa-
paya, strawberries, kiwi, oranges and other citrus fruits,
green and red peppers, broccoli, spinach, and raw toma-
toes), vitamin E, selenium, zinc, copper, and flavonoids
(found in grapes, apples, cherries, broccoli, radishes, beets,
seeds, flowers, green tea, black tea, soy, Ginkgo biloba,
thistle, and cranberries); and e) fiber (found in fruits and
cereals). The MSD group received specific menus includ-
ing the aforementioned food items. To determine the par-
ticipants’ typical diet prior to the intervention, a 24-hour
recalls was used.
In both groups the diet was administered using a food
equivalents system.
For this purpose, food replicas were used so that pa-
tients and their parents/guardians could learn to recognize
a healthy diet, and menus were tailored according to the
age- and gender-required calories of each participant. Thepatients received their diet plans in writing, containing a
graphic representation of the food groups, menu proto-
types and general recommendations for healthy nutrition.
The calorie content prior to and after the intervention
was calculated using the computer software NUTRIPAC,
which was validated in Mexico and contains Hispanic
food data [25,26]. Using this software, the calorie con-
tent as well as the macro- and micronutrient content of
the diets of the intervened patients was determined
based on their 24-hour recalls entries.
Both groups received general recommendations about
performing physical activity.
Patients were evaluated every three weeks over the
intervention to measure diet compliance and reinforce the
indicated diet. For this purpose, 24-hour recalls were used.
During the consultations, doubts about the indicated diet
were resolved, the principles of the intervention were rein-
forced, barriers/difficulties were discussed, and specific
suggestions for better diet compliance were made.
Using the aforementioned technique, measurements were
registered during each visit for the following parameters:
body composition, dietary assessment, waist and hip cir-
cumference measurements, and BP.
Paired Student’s t-test was used for dependent samples
to compare the effect of the intervention on the anthropo-
metric, biochemical, and dietary variables in both groups.
Macnemar’s test was used to identify the effect of the
intervention on cardiovascular risk factors. Data analysis
was performed using the SPSS version 20 Package.
Results
A total of 7 patients (4 from MSD group and 3 from the
standard diet) were eliminated from the analysis because
they did not attend 90% of the scheduled appointments
to assess diet compliance. At the beginning of the inter-
vention, no statistically significant differences were found
in sociodemographic, biochemical, clinical, and anthropo-
metric variables, indicating that the study population was
homogenously distributed in both groups, as can be ob-
served in Table 1.
The effect of the 16-week intervention on the anthropo-
metric and biochemical variables for both study groups is
presented in Table 2. In the MSD group a decrease in the
following measurements was observed (p < 0.05): BMI, fat
mass, lean mass, glucose, TC. TG, and LDL-C levels. Fur-
thermore, a statistically significant increase in HDL-C was
observed in the MSD group, (p < 0.05). The frequency of
components of MetS also significantly decreased in the
group following the MSD (p < 0.05). With regard to MetS,
the group following the MSD showed a decrease of 45%
in MetS, and as such, a significant difference after 16-
week of intervention, (p < 0.05). The standard diet group
decreased the glucose mean levels and the frequency
glucose > 100 mg/dL after 16-week intervention (p <
Table 1 Baseline characteristics of obese children and adolescents according to treatment group
Mediterranean style diet n = 24 Standard diet n = 25 p-value
Male [n (%)] 13 (54) 10 (40) 0.393
Age (years) 11.2 ± 2.7 11.4 ± 2.9 0.737
Obesity onset age (years) 5.58 ± 3.0 4.3 ± 3.2 0.163
Weight (kg) 64.05 ± 10.1 62.2 ± 20.9 0.751
Height (cm) 151.5 ± 12.2 150.5 ± 14.2 0.790
BMI (kg/m2) 27.3 ± 3.9 26.7 ± 4.7 0.631
Pre-pubertal [n (%)] 11 (46) 13 (52) 0.778
Schooling (years completed) 5.2 ± 2.3 5.1 ± 2.8 0.949
High BP levels [n (%)] 1 (4) 3(12) 0.609
Acanthosis nigricans [n (%)] 18 (75) 21 (84) 0.496
Low birth weight <2.5 kg [n (%)] 1 (4) 4 (16) 0.603
High birth weight >4.0 kg [n (%) 1 (4) 3 (12) 0.204
HOMA IR≥ 3 [n (%)] 15 (62) 17 (68) 0.310
Fasting glucose (mg/dL) 98.7 ± 5.5 98.4 ± 5.8 0.849
Glucose 120 minutes (mg/dL) 118.2 ± 16.5 111.3 ± 27.2 0.292
Fasting Insulin (μUI/dL) 18.6 ± 12.8 19.1 ± 12.7 0.896
Insulin 120 minutes (μUI/dL) 107.8 ± 102.9 129.3 ± 142.1 0.548
HOMA-IR 4.5 ± 3.0 4.7 ± 3.3 0.840
Metabolic syndrome [n (%)] 16 (66) 10 (40) 0.060
Data are presented as mean ± SD and frequencies and percentages; the p-value was calculated with Student’s t-test and Chi square test.
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mass increase in the same period of time. This group
showed no significant changes in MetS proportion, as
can be seen in Figure 1.
With respect to diet composition, the MSD group ex-
hibited a significant increase in the consumption of diet-
ary fiber, proteins, omega 9 fatty acids, zinc, selenium,
vitamin E, and flavonoids, furthermore, they consumed
fewer saturated fatty acids (p < 0.05); No significant
changes were identified in the components of the diet in
the standard diet group (Table 3).
The consumption of zinc, and vitamin E from both diets
is shown in Figure 2, it can be observed a greater consump-
tion of these nutriments in the MSD group.
Similarly, the changes in dietary consumption of omega
9 fatty acids, selenium, and vitamin C during the 16-week
intervention are depicted in Figure 3; the MSD group had
a greater consumption of these nutriments.
Discussion
The results of the present study demonstrate the effect
of a nutritional intervention with an MSD in obese children
exhibiting at least one MetS component. The benefits of a
Mediterranean diet on health, cardiovascular disease
prevention, and other aliments have been shown in
adult populations [27,28]. The characteristics of our study
participants, who were obese and exhibited at least one
cardiovascular risk factor, made them ideal candidates forthe implementation of a diet aimed at decreasing these
factors. The intervention consisted of the administration
of a nutrition plan containing foods that are part of a
Mediterranean diet.
Although the benefit of a Mediterranean diet in adults
is widely recognized, little is known about its effect in
children. Studies have reported an association between
diet compliance and obesity prevalence in children and
adolescent populations [29].
Even though adherence to the Mediterranean diet is im-
portant, other factors also influence obesity prevention,
such as eating habits, customs, and physical exercise [30].
Thus, it is necessary to strengthen adherence to the Medi-
terranean diet while also addressing other factors that
contribute to obesity and metabolic alterations.
After a 16-week intervention, the MSD group decreased
BMI but without changes in weight. Lopez Alarcon et al.,
who conducted an intervention study supplementing
900 mg omega 3 fatty acids to a population aged 9 to
18 years, they reported not changes in weight or BMI [31].
Similarly Fernandez et al., who compared three different
diets over a three-month period in an adult population
and did not observe an association between body weight
and the Mediterranean diet [32]. Although the MSD had
no significant effect on body weight after four months of
intervention, a decrease in BMI and an increase in height
were observed. The nutrition plan was administered ac-
cording to weight, sex, age, and eating habits and was not
Table 2 Differences in cardiovascular risk factors in obese children and adolescents after 16-week follow-up









Δ baseline versus 16-week p*
Mean difference 95% CI Mean difference 95% CI
Weight (Kg) 64.0 ± 19.1 63.5 ± 18.6 0.5 −1.8, 0.7 0.369 62.2 ± 20.9 63.9 ± 19.8 −1.7 −2.9, −0.5 0.007
Height (m) 1.51 ± 0.12 1.54 ± 0.11 0.03 0.01, 0.04 0.001 1.50 ± 0.14 1.52 ± 0.12 0.02 0.01, 0.03 0.001
BMI (kg/m2) 27.3 ± 3.9 26.2 ± 3.9 −1.10 −1.4, −0.7 0.001 26.7 ± 4.7 26.8 ± 4.5 0.1 −0.2, 0.6 0.374
Waist (cm) 89.0 ± 12.6 88.8 ± 12.7 −0.2 −2.5, 2.0 0.826 84.8 ± 12.2 87.3 ± 11.7 2.5 −0.2, 5.2 0.072
Hip (cm) 97.0 ± 10.9 96.1 ± 10.8 −0.9 −2.8, 0.9 0.303 94.2 ± 12.2 95.2 ± 11.4 1.0 −1.0, 3.0 0.308
Waist/hip ratio 0.913 ± 0.05 0.918 ± 0.06 0.005 −0.015, 0.024 0.600 0.89 ± 0.06 0.91 ± 0.06 0.02 −0.01, 0.04 0.325
MAC (cm) 29.4 ± 4.2 29.7 ± 4.6 0.3 −0.2, 0.9 0.222 28.2 ± 4.7 29.9 ± 3.5 1.7 0.5, 2.7 0.004
TSF (mm) 27.0 ± 7.0 25.5 ± 4.8 −1.5 −3.0, 0.04 0.056 27.9 ± 4.6 28.6 ± 5.0 0.7 −1.2, 2.7 0.444
Fat mass (kg) 26.0 ± 11.2 23.4 ± 10.6 −2.6 −3.4, −1.8 0.001 24.2 ± 9.5 24.5 ± 8.46 0.3 −0.7, 1.3 0.575
Lean mass (kg) 38.0 ± 10.9 40.1 ± 10.9 2.1 0.8, 3.2 0.001 38.0 ± 13.2 39.5 ± 14.0 1.5 0.2, 2.6 0.018
SBP (mmHg) 103.0 ± 11.9 100.3 ± 7.94 −2.7 −7.2, 1.8 0.229 101.2 ± 13.4 100.6 ± 10.7 −0.6 −4.2, 3.0 0.720
DBP (mmHg) 64.0 ± 7.7 62.3 ± 8.6 1.7 −6.0, 2.6 0.435 61.7 ± 9.6 63.2 ± 7.6 1.5 −1.6, 4.6 0.329
Glucose (mg/dL) 98.7 ± 5.5 88.2 ± 3.81 −10.5 −13.1, −7.7 0.001 98.4 ± 5.8 93.5 ± 5.73 −4.9 −8.1, −1.7 0.004
TC (mg/dL) 177.3 ± 24.6 146.3 ± 21.4 −31.0 −42.5, −19.6 0.001 170.2 ± 34.6 166.8 ± 32.3 −3.4 −16.5, 9.7 0.599
TG (mg/dL) 214.4 ± 92.9 124.4 ± 31.1 −90.0 −126.5, −53.4 0.001 197.9 ± 107.3 167.4 ± 78.5 −30.5 −61.9, 1.03 0.057
HDL-C (mg/dL) 34.7 ± 6.3 43.7 ± 9.6 9.0 4.0, 14.0 0.001 31.9 ± 8.5 34.8 ± 12.0 2.9 −2.2, 7.9 0.265
LDL-C (mg/dL) 99.7 ± 26.8 77.7 ± 18.6 −22.0 −33.8, −10.3 0.001 98.7 ± 26.4 98.6 ± 29.7 −0.1 −13.0, 12.7 0.981
n (%) n (%) ** n (%) n (%) **
Glucose >100 mg/dL 8 (33.8) 0 - - 0.007 14 (56) 5 (20) - - 0.012
TG >150 mg/dL 21 (88) 2 (8) - - 0.001 13 (52) 14 (56) - - 0.999
TC > 200 mg/dL 5 (21) 0 - - 0.025 5 (20) 5 (20) - - 0.999
HDL-C≤ 40 mg/dL 20 (83) 7 (29.2) - - 0.002 21 (84) 20 (80) - - 0.999
LDL-C >100 mg/dL 10 (42) 4 (17) - - 0.058 10 (40) 10 (40) - - 0.999
MetS 16 (66.7) 5 (20.8) - - 0.003 10 (40.0) 11 (44.0) - - 0.999
MAC. media arm circumference. SBP = systolic blood pressure, DBP = diastolic blood pressure, TC = total cholesterol, TG = triglycerides, HDL-C = high-density lipoprotein cholesterol, LDL-C = low-density lipoprotein

















Figure 1 Changes in metabolic syndrome (MetS) frequency
according to diet type. Mediterranean-style diet (MSD) - MetS
presented as frequency, difference at baseline and at 16 weeks
follow-up was analyzed using McNemar related-samples test (p = 0.003).
Standard diet (SD)- MetS presented as frequency, difference at baseline
and at 16 weeks follow-up was analyzed using McNemar
related-samples test (p = 0.999).
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plain why the population did not experience any weight
loss. On the contrary, the standard diet group increased
1.7 kg average, with no effect on the BMI, possibly due to
the height increase.
It could be explained by the dietetic patterns, the lack
of physical activity, and the sedentary behavior of stud-
ied subjects. Our results agree with those that have re-
ported nutritional and physical activity and motivational
interviewing training interventions in similar popula-
tions [33,34].
Abdominal obesity was measured by WC, which has
been reported to be a strong indicator of cardiometabolic
risk in children and adolescents [35,36]. We did not ob-
serve a significant change in this indicator at the end of
the intervention. It has been reported that higher scores
for diet compliance are inversely associated with WC and
waist-height ratio in young populations [37]. We mea-
sured body composition using bioelectrical impedance
and did observe significant differences in the reduction of
fat mass and lean mass in the group with MSD. Changes
in these indicators have been reported in the Mediterra-
nean diet adherence [38].
High BP levels are an important component of MetS. A
total of 4 patients with high BP levels were identified at
the beginning of the study. No significant changes in the
average SBP and DBP values were found, unlike what has
been reported previously for young populations following
the Mediterranean diet, albeit with higher compli-
ance rates [39]. One possible explanation could be
that our study population already exhibited age- and
sex-appropriate BP values.
Although the development of T2DM is still more
common in adults, an increase in this disease has been
reported in children and adolescents [40]. Althoughgenetic factors predispose individuals to the develop-
ment of diabetes, obesity, lifestyle, poor living condi-
tions, and social factors further contribute to it [41]. In
Mexico, a 0.6% prevalence of diabetes in the pediatric
population has been reported, which further increases to
1.3% in obese children [42]. In our study population, 8
participants receiving the MSD and 14 participants re-
ceiving the standard diet presented with glucose values
greater than 100 mg/dL. This is consistent with previous
reports that obesity continues to be a determining factor
in fasting glucose alterations and IR [43].
In the present study, we observed a decrease in fasting
glucose levels in both intervention groups. However, the
MSD group exhibited the most significant decrease. A
reduction in simple sugar consumption was suggested
for both diets; thus, a possible explanation for this obser-
vation could be that the MSD group had a higher fiber
content, which could have a greater influence on redu-
cing glucose levels. Furthermore, 65% of the total
assessed population presented with IR, assessed by
HOMA-IR >3, which is similar to what has been previ-
ously reported by other groups [44]. Importantly, an in-
adequate lifestyle leads to a higher risk of developing
T2DM.
The results of the current study demonstrated that
MSD decrease CT, TG and LDL-C levels and also in-
crease HDL-C after the 16-week. Similar results have
been previously reported in obese children and adoles-
cents following a hypocaloric diet low in simple carbo-
hydrates and high in vegetables and fiber-rich cereals
[43]. Other authors have reported in children with
hypercholesterolemia decrease in TC and LDL-C levels
with a Mediterranean diet [45].
The results are relevant in regard to these indicators,
given that alterations in the lipid profile are recognized
as an important factor in cardiovascular risk among the
overweight and obese pediatric population [44]. In the
standard diet group no significant changes were ob-
served in lipid profile.
One of the characteristics of the administered MSD
was its high fiber content, which is most likely respon-
sible for the reduction in glucose and lipid levels, as
mentioned previously [46]. Similar effects on metabolic
indicators have been reported for pre-diabetic Mexican
adults following a diet with a 50% reduction in carbohy-
drates and higher fruit, vegetable, and fiber content [47]
The fiber consumption in the MSD group was greater
than 16 g. This is similar to the value reported for a
population on a diet with many food items typical of a
Mediterranean diet [48]. The MSD group increased sig-
nificantly the fiber consumption, this is beneficial, since
it has been reported the association between a low fiber
diet and higher adiposity and cardiovascular risk factors
during childhood and adolescence [49,50]. Another
Table 3 16-week diet comparison in obese children and adolescents with any MetS component









Δ baseline versus 16-week p*
Mean difference 95% CI Mean difference 95% CI
Energy (Kcal) 1848.9 ± 493.5 1706.7 ± 355.3 −142.1 −322.6, 38.3 0.117 1754.7 ± 570.4 1651.7 ± 367.4 −103.0 −285.2, 79.4 0.255
Fiber (g) 11.0 ± 4.7 16.9 ± 4.85 5.9 3.7, 8.0 0.001 9.10 ± 5.1 8.05 ± 4.1 −1.05 −3.5, 1.5 0.423
Cholesterol (mg) 167.6 ± 60.5 144.9 ± 61.5 −22.6 −49.0, 3.8 0.090 295.9 ± 246.6 210.7 ± 206.9 −85.2 −237.2, 66.8 0.259
CHO (g) 230.3 ± 72.4 203.1 ± 33.9 −27.2 −57.3, 2.9 0.075 204.5 ± 93.4 197.7 ± 72.3 6.8 −30.6, 17.0 0.562
CHO (%) 49.5 ± 6.8 48.0 ± 4.4 −1.5 −4.6, 1.6 0.428 45.8 ± 10.2 47.0 ± 9.9 1.2 −2.8, 5.2 0.551
Proteins (g) 69.3 ± 18.4 72.3 ± 11.5 3.0 −4.9, 10.8 0.449 60.9 ± 16.8 58.2 ± 17.0 −2.7 −9.8, 4.5 0.458
Proteins (%) 15.2 ± 3.0 17.1 ± 2.1 1.9 0.4, 3.4 0.012 14.3 ± 3.1 14.0 ± 3.3 −0.3 −1.4, 0.9 0.688
Lipids (%) 35.6 ± 6.4 35.1 ± 4.8 −0.5 −3.3, 2.3 0.719 39.9 ± 9.4 38.9 ± 9.4 −1.0 −5.1, 3.2 0.640
SFA (%) 30.2 ± 3.9 27.7 ± 4.2 −2.5 −4.6, −0.3 0.024 34.4 ± 9.6 33.1 ± 7.5 −1.3 −5.7, 3.1 0.556
MUFA (%) 41.1 ± 2.7 42.3 ± 3.8 1.2 −0.2, 2.7 0.094 40.4 ± 5.7 40.0 ± 4.2 −0.4 −2.5, 1.8 0.742
PUFA (%) 28.7 ± 4.0 29.9 ± 4.2 1.2 −0.4, 2.9 0.144 25.2 ± 5.6 26.8 ± 5.9 1.6 −1.4, 4.7 0.292
Omega 9 FA (g) 24.9 ± 10.4 30.2 ± 12.4 5.3 0.8, 9.7 0.021 27.7 ± 12.9 24.4 ± 9.9 −3.3 −9.9, 3.4 0.330
Sodium (mg) 1418.8 ± 367.2 1326.4 ± 432.6 −92.33 −270.0, 85.3 0.294 1297.4 ± 578.7 1182.9 ± 553.5 −114.5 −366.0, 137.0 0.357
Potassium (mg) 1614.8 ± 515.5 1545.1 ± 374.0 −69.6 −257.3, 118.2 0.007 1491.6 ± 599.7 1565.9 ± 656.6 74.3 −168.7, 317.3 0.534
Zinc (mg) 4.7 ± 1.4 6.4 ± 2.5 1.7 0.7, 2.5 0.001 3.7 ± 1.65 4.0 ± 2.03 0.3 −0.4, 1.0 0.446
Selenium (μg) 24.0 ± 8.5 35.4 ± 8.4 11.4 6.6, 16.0 <0.001 14.9 ± 18.2 16.7 ± 11.65 1.8 −3.5, 7.2 0.490
Vitamin C (mg) 52.0 ± 40.5 85. 6 ± 79.7 33.6 2.1, 64.8 0.037 67.6 ± 62.9 55.5 ± 70.9 −12.1 −43.4, 19.2 0.435
Vitamin E (mg) 3.6 ± 2.8 7. 9 ± 2.9 4.3 2.6, 5.8 <0.001 1.44 ± 2.2 1.37 ± 2.6 0.07 −0.93, 1.08 0.880
Flavonoids (mg) 12.4 ± 5.1 20.2 ± 5.4 7.8 5.4, 10.0 <0.001 2.9 ± 4.25 2.7 ± 4.1 −0.2 −2.2, 1.7 0.819
Kcal = kilocalories, g = grams, mg =milligrams, CHO = carbohydrates, FA = fatty acids, SFA = saturated fatty acids, MUFA =monounsaturated fatty acids, PUFA = polyunsaturated fatty acids. CI = Confidence Intervals


















Figure 2 Dietary consumption of zinc and vitamin E according to the type of diet. Mediterranean-style diet (MSD) – Zinc and vitamin E are
expressed as mean (mg), the difference in consumption at baseline and 16 weeks follow-up was analyzed with a paired t test (p = 0.001,
p < 0.001 respectively). Standard diet (SD) – Zinc and vitamin E are expressed as mean (mg), the difference in consumption at baseline and
16 weeks was analyzed with a paired t test (p = 0.446, p = 0.880 respectively).
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http://www.biomedcentral.com/1471-2431/14/175benefit of the MSD was the increased protein intake, this
is relevant because these nutrients are essential for a
healthy growth and development in this population.
One characteristic of the MSD in this study was the
greater consumption of antioxidants, such as selenium,
vitamins C and E, dietary fiber and few simple sugars,
this could explain that MSD group exhibited a higher
significantly average consumption of omega 9 fatty acids,
dietary fiber and less consumption of SFA, different to
what we found in the standard diet group.
MSD diet group exhibited important benefits in redu-
cing several MetS components, which is consistent with
the decrease in metabolic risk indicators reported in
women following a diet supplemented with antioxidants
[51]. MetS was identified in a significant proportion ofFigure 3 Dietary consumption of omega 9 fatty-acids, selenium, vitam
Omega 9 fatty acids (g), selenium (μg), and vitamin C (mg) are expressed a
follow-up was analyzed with a paired t test (p = 0.021, p < 0.001, p = 0.037
(μg), and vitamin C (mg) are expressed as mean, the difference in consump
t test (p = 0.330, p = 0.490, p = 0.435 respectively).both groups. However, at the end of the intervention,
the MSD group showed a significantly reduced propor-
tion of patients exhibiting MetS in regard to the basal
metabolic rate. As previously reported, our results sup-
port the usefulness of providing children exhibiting
obesity and MetS with an MSD aimed at increasing con-
sumption of fiber, proteins, omega 3 and omega 9 fatty
acids, zinc, selenium, vitamin E and flavonoids [15].
These results further support the importance of intro-
ducing an MSD to at-risk populations. In addition, a
healthy lifestyle, adequate eating habits, and physical ac-
tivity should be encouraged, while less time should be
spent watching TV, working at the computer, and play-
ing video games. A lack of physical activity has been re-
ported to be a major predicting factor of childhoodin C according to the type of diet. Mediterranean style diet (MSD) –
s mean, the difference in consumption at baseline and 16 weeks
respectively). Standard diet (SD) – Omega 9 fatty acids (g), selenium
tion at baseline and 16 weeks follow-up was analyzed with a paired
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http://www.biomedcentral.com/1471-2431/14/175obesity, superseding compliance with a Mediterranean
diet [52]. Physical activity was not evaluated in this
study, both groups received general recommendations in
this area. Future research should be carried out to evalu-
ate the efficacy of combining a MSD with physical activ-
ity in childhood obesity.
A limitation of our study was the short intervention
time, thus, the sustainability of longer intervention time
should be assessed. We also consider that this strategy
should be evaluated with a larger number of participants
to adjust the effect by variables such as age, socio-
economic status, physical activity and sedentary status.
Our results suggest that in the Mexican population, a
longer intervention time with an MSD, together with
lifestyle modifications could have a greater impact on
the pediatric population exhibiting obesity and at least
one MetS component.
Conclusions
An MSD improves the BMI, glucose, and lipid profile in
children and adolescents exhibiting obesity and any MetS
component.
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